Insights into the SIRFLOX study.

Peter Gibbs speaks to Laura Dormer, Editorial Director: Peter Gibbs is a medical oncologist at the Western and Royal Melbourne Western Hospitals (Australia), and a laboratory head at the Walter and Eliza Hall Institute (Australia). He has a particular interest in translational research related to prognostic and predictive biomarkers for colorectal cancer. He is also heavily involved in clinical research, including being lead investigator of multiple international Phase III trials. He leads several national and international cancer registries, capturing comprehensive treatment and outcome data for patients treated in routine clinical care.